Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
fda
life sciences
national blog main
boston blog main
boston top stories
indiana blog main
indiana top stories
startups
480 biomedical
aimmune therapeutics
allergy
amgen
anaphylaxis
andrew oxtoby
arsenal medical
battlefield
bob langer
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
chronic migraine
chronic rhinosinusitis
covid-19
daniel edelman
deals
detroit blog main
detroit top stories
disease
disrupt sf 2017
drug delivery
drugs
eli lilly
eosinophilic esophagitis
episodic migraine
events
food allergy
What
late
4
×
approval
approved
developed
drug
fda
new
therapeutics
time
treat
won
agency
aimmune
allergy
announced
available
awarded
biotech
cancer
class
company
consequence
critical
day
debut
decision
despite
determining
developing
dozens
eli
friday
great
guesswork
having
headache
immunotherapy
important
ipo
lilly
Language
unset
Current search:
late
×
biotech
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@techcrunch.com
6 years ago
Ourotech is taking the guesswork out of cancer treatment